INTS · Intensity Therapeutics, Inc.
$4.43
+0.04 (+0.91%)
At close · Jul 23
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the cash and cash equivalents as of March 31, 2026, the Company's ability to continue its operations thereafter is dependent on obtaining additional capital, which is not within the Company's control. As a result, the Company believes there is substantial doubt about its ability to continue as a going concern.”View the 10-Q filed May 7, 2026
Market Cap
$11.97M
Shares
2.70M
No listed options were found for INTS.